Archives
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-09-10
The reference study identifies ALDH2 as more than a mitochondrial aldehyde-detoxification enzyme: its activation can extend the early cardiomyocyte proliferative window and increase proliferation in adult mice exposed to pressure overload. These findings connect ALDH2 activity with cardiac regeneration and provide a mechanistic framework for evaluating ALDH2-directed interventions in heart-failure models.
-
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-09-10
Sulfo-NHS-SS-Biotin provides water-compatible, amine-reactive biotinylation for accessible lysine side chains and N-terminal amines, supporting protein labeling, affinity capture, and reversible workflows. It is appropriate for aqueous protein or intact-cell surface labeling, but not for labeling intracellular targets in nonpermeabilized cells, and its solution must be prepared immediately before use.
-
3X (DYKDDDDK) Peptide: Workflow Guide
2026-09-09
Use the 3X (DYKDDDDK) Peptide as a practical control, competitive eluent, and assay-development reagent for FLAG-tagged proteins. This guide connects routine detection and purification workflows with stability questions raised by Chlamydia effector biology, while highlighting metal sensitivity and construct-design tradeoffs.
-
UK-5099 in Mitochondrial Immunometabolism
2026-09-09
UK-5099, also called PF-1005023, gives researchers a controllable way to restrict mitochondrial pyruvate entry while measuring cytokines, respiration, ATP balance, and glucose handling. Its greatest value is comparative: the same metabolic perturbation can be tested in standardized whole blood, isolated mitochondria, insulinoma cells, and glucose-tolerance models.
-
Bovine Ovarian Morphology, Redox Imbalance, and Apoptosis
2026-09-08
The reference study shows that simple morphology-based grouping of bovine ovaries corresponds to coordinated oxidative stress and apoptotic changes in ovarian tissue, follicular fluid, and granulosa cells. Its multi-compartment design identifies granulosa cells as a particularly sensitive functional readout and offers a practical framework for reducing biological variability in cattle assisted reproductive technology studies.
-
Lapatinib Research Workflows for EGFR and HER2
2026-09-07
Build a receptor-aware workflow around Lapatinib, also known as GW572016, from biochemical kinase testing through proliferation, invasion, and angiogenesis readouts. The framework separates direct EGFR/HER2 target engagement from phenotype-first findings in HER2-low models, improving targeted cancer therapy research and troubleshooting.
-
Gemcitabine Workflows for DNA Damage and Cancer Research
2026-09-07
Build mechanism-resolved Gemcitabine experiments that connect replication stress with checkpoint signaling, apoptosis, and tumor–immune metabolism. This workflow combines practical dosing guidance with a cholangiocarcinoma use case for testing chemotherapy sensitization.
-
Bazedoxifene: From ER Binding to Bone Assays
2026-09-05
Bazedoxifene is a selective estrogen receptor modulator whose value in osteoporosis research depends on matching molecular, cellular, and skeletal endpoints. This guide translates clinical evidence into a practical assay strategy for studying bone mineral density enhancement and postmenopausal osteoporosis.
-
EdU Imaging Kits (Cy3) for S-Phase Analysis
2026-09-05
EdU Imaging Kits (Cy3) combine click-chemistry specificity with fluorescence microscopy and flow cytometry flexibility for measuring DNA synthesis. The workflow is especially useful when researchers need to preserve morphology and antigen-binding sites while comparing developmental, regenerative, cancer, or genotoxic responses.
-
Sulfisomidine: hPON1 Assay & Antibacterial Workflows
2026-09-04
Sulfisomidine is a dual-purpose research reagent for probing bacterial folate metabolism and mixed-type inhibition of human serum paraoxonase 1. This workflow-focused guide shows how to prepare, dose, fit, and troubleshoot Sulfisomidine assays while preserving interpretive value across enzyme, cell, and environmental studies.
-
CNQX in Reliable Excitotoxicity Assays
2026-09-04
CNQX, also known as 6-cyano-7-nitroquinoxaline-2,3-dione, helps researchers distinguish AMPA/kainate-driven excitation from NMDA-dependent and non-glutamatergic effects in neuronal viability and cytotoxicity workflows. This scenario-based guide explains how the documented formulation, potency, solubility, and storage specifications of SKU B6222 support practical assay standardization.
-
SmMAPK3–SmRAS1 Phosphorylation in Salvia miltiorrhiza
2026-09-03
The reference study identifies a salicylic acid-responsive SmMAPK3–SmRAS1 signaling module that controls salvianolic acid accumulation through phosphorylation of SmRAS1 at Ser178. Its combination of transgenic hairy roots, interaction screening, kinase assays, and coexpression experiments provides a mechanistic framework for improving phenolic-acid production through post-translational regulation.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-02
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with targeted metabolic intervention and cytokine measurement. The workflow preserves the complexity of human blood while improving comparability for cohort-scale immunometabolism and metabolic disorder research.
-
EMD638683: SGK1 Inhibitor Evidence
2026-09-02
EMD638683 is a selective SGK1 inhibitor that suppresses SGK-dependent NDRG1 phosphorylation and supports mechanistic studies of vascular stiffness, tumor biology, and cell survival. Evidence spans biochemical, cellular, mouse, and endothelial models, but the compound remains a research reagent rather than a validated clinical treatment.
-
Hoechst 33258 for KRas–TNT Assay Design
2026-09-01
Learn how Hoechst 33258, a bis-benzimide DNA stain, can strengthen KRas tunneling-nanotube studies through nuclear registration, cell-state control, and orthogonal validation. This guide emphasizes interpretation safeguards rather than treating nuclear fluorescence as evidence of oncogenic protein transfer.